Universal Cells
Chelsea Maguire is a Scientist at Universal Cells with previous experience as a Principal Research Associate at the same company and a Senior Research Technologist at Northwestern University - The Feinberg School of Medicine. Prior to this, Chelsea worked as a Clinical HLA Laboratory Work Study at Rush University Medical Center and as a Research Technologist at Northwestern University. Chelsea also has experience as a REU Chytrid Research Assistant at the University of Maryland and as a Research Assistant at the University of Illinois at Urbana-Champaign. Chelsea holds a Master of Science degree in Clinical Laboratory Science/Medical Technology/Technologist from RUSH University and a Bachelor of Science degree in Integrative Biology from the University of Illinois Urbana-Champaign.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.